FORMULATION AND CHARACTERIZATION OF LAFUTIDINE NANOSUSPENSION FOR ORAL DRUG DELIVERY SYSTEM


Noor Mohammed Dawood, Shaimaa Nazar Abdal-hammid, Ahmed Abbas Hussien

Abstract


Objective: The objective of this study was to prepare nanosuspension of a practical water insoluble antiulcer drug which is lafutidine to enhance the solubility, dissolution rate with studying the effect of different formulation variables to obtain the best formula with appropriate physical properties and higher dissolution rate.  

Methods: Nanosuspension of lafutidine was prepared using solvent anti-solvent precipitation method using Polyvinylpyrrolidone K-90(PVP K-90) as the stabilizer. Ten formulations were prepared to show the effect of different variables in which two formulations showed the effect of stabilizer type, three formulations showed the effect of stabilizer concentration, two formulations showed the effect of combination of polymer with surfactant such as tween 80, three formulations show the effect of stirring speed and three formulations prepare to show the effect of addition of co-surfactant such as tween 20. All these formulations are evaluated for their particle size and entrapment efficiency and in vitro release. The selected one was evaluated for zeta potential, scanning electron microscope, atomic force microscopy, fourier transform infrared spectroscopy, differential scanning calorimetry , saturation solubility and stability study.

Results: The formulations (F3-F10) were in the nano size. The optimum concentration of the stabilizer was in the formulation when the drug: polymer: surfactant ratio 1:4:4 and the optimum stirring speed was 1500 rpm. Dramatic effect on the particle size reduction was found by the addition of co-surfactant (tween 20) in formulation F7 that has a particle size 15.89±1.8 nm. The selected formula F7 showed an enhanced dissolution profile (10 min) compared to the pure drug at all-time intervals.

Conclusion: The results show that the formulation that contains drug: PVP-K90: tween 80: tween 20 in ratio 1:4:2:2 is the best one and can be utilized to formulate lafutidine nanosuspension.

References


- Marano S, Barker SA, Raimi-Abraham BT, Missaghi S, Rajabi-Siahboomi A, Craig DQ. Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinning. Eur J Pharm Biopharm. 2016;103:84-94.

- Martin’s physical pharmacy and pharmaceutical sciences, 4th Edition, 220.

- Loh ZH, Samanta AK, Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10:255-74.

- K Ramesh B, Chandra S, Podile K. Formulation and evaluation of poorly soluble etravirine by spray drying method. Int J Pharm Pharm Sci. 2015;7:98-103.

- Bhairav BA, Bachhav JK, Saudagar RB. Review on solubility enhancement techniques. Asian J Pharm Res. 2016; 6:175-80.

- Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution, and bioavailability. Asian J Pharm Sci. 2014;9:304-16.

- Kayaert P, Van den Mooter G. Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? a case study with naproxen and cinnarizine. Eur J Pharm Biopharm. 2012;81:650-6.

- Amin MA, Osman SK, ALY UF. Preparation and characterization of ketoprofen nanosuspension for solubility and dissolution velocity enhancement. Int J Pharm Bio Sci. 2013; 4:768-80.

- Sutradhar KB, Khatun S, Luna IP. Increasing possibilities of nanosuspension. J Nanotech. 2013 .

- Agrawal G, Atrey R, Mishra P. A stability-indicating high performance liquid chromatographic analytical method for the determination of lafutidine in the tablet.Der Pharm Let. 2015;7: 38-43.

- Parveen A, Reddy RS. Formulation and in vitro evaluation of gastroretentive bilayer floating tablets of clarithromycin and lafutidine. Int J Pharm Tech. 2014;6: 6651-70.

- Lolitas D. Design and evaluation of lafutidine floating tablets for controlled release by using semi-synthetic and natural polymer. J Drug Disc Therap. 2014;2.

- Sravanthi N, Bandari D. Effect of super disintegrants on solubility and dissolution rate of lafutidine. Int J Adv Tech Eng Sci. 2015;3: 275-89.

- Patel MD, Patel GD, Patel NC. Formulation and optimization of the raft-forming chewable tablet containing lafutidine. Int J Pharm Sci Drug Res. 2015;7: 229-34.

- Patel DM, Patel DG, Patel CN. Formulation and optimization of raft forming chewable tablet containing lafutidine. Int J Pharm Sci Drug Res. 2015;7:229-34.

- . Pandya VM, Patel JK, Patel DJ. Formulation, optimization and characterization of simvastatin nanosuspension prepared by nanoprecipitation technique. Der Pharm Lettre. 2011;3:129-40.

- Jassim ZE, Hussein AA. Formulation and evaluation of clopidogrel tablet incorporating drug nanoparticles. Int J Pharm Pharm Sci. 2014;6:838-51.

- Shid RL, Dhole SN, Kulkarni N, Shid SL. Formulation and evaluation of nanosuspension formulation for drug delivery of simvastatin. Int J Pharm Sci Nanotech. 2014;7:2650-65.

- SahuBP, Das MK. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci. 2014;4:189-97.

- Papdiwal A, Pande V, AherS. Investigation of an effect of different stabilizers on a formulation of zaltoprofen nanosuspension. Int J Pharm Sci Rev Res. 2014:244-9.

- Deore S, Nerkar P, Mahajan H, Ige P. Formulation and evaluation of nanosuspension formulations polymers.2014.

- Gadad AP, Naik SS, Dandagi PM, Bokmal UB. Formulation and evaluation of gastroretentive floating microspheres of lafutidine. Ind J Pharm Edu Res. 2016;50: Suppl76-81.

- Kakran M, Sahoo GN, Li L. Fabrication of nanoparticles of silymarin, hesperetin and glibenclamide by evaporative precipitation of nanosuspension for fast dissolution. Pharm Anal Acta. 2015;6:2.

- Jassem NA, Rajab NA. Formulation and in vitro evaluation of azilsartan medoxomil nanosuspension. 2017;9:110-19.

- Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Advanced drug delivery reviews. 2011;63:456-69.

- Sinha B, Müller RH, Möschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013:1-15.

- Amin MA, Osman SK, AlyUF. Preparation and characterization of ketoprofen nanosuspension for solubility and dissolution velocity enhancement. Int J Pharm Bio Sci. 2013;4:768-80.

- Krishna K, Hiral K, NavinS, Mahesh D. The impact of critical variables on properties of nanosuspension: a review. Int J Drug Dev Res. 2015.

- Rachmawati H, Shaal LA, Müller RH, Keck CM. Development of curcumin nanocrystal: physical aspects. J Pharm Sci. 2013;102:204-14.

- Zu Y, Sun W, Zhao X, Wang W, Li Y, Ge Y, et al. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid anti-solvent precipitation. Eur J Pharm Sci. 2014;53:109-17.

- Senthil Kumar P, Arivuchelvan A, Jagadeeswaran A, Subramanian N, Senthil Kumar C, Mekala P. Formulation, optimization and evaluation of enrofloxacin solid lipid nanoparticles for sustained oral delivery. Asian J Pharm Clin Res 2015;8: 231-6.

- Yeole BD, Patil RP, Lone KD, TekadeAR. Preparation of nanoparticles of poorly water soluble dronedarone by antisolvent addition technique using natural polymer as a stabilizer. J Pharm Res Clin Prac. 2016; 6:8-16.

- Gera S, Talluri S, Rangaraj N, Sampathi S. Formulation and evaluation of naringenin nanosuspensions for enhancement. AAPS Pharm Sci Tech. 2017:1-2.

- Maaz A, Abdelwahed W, Tekko IA, TrefiS. Influence of nanoprecipitation method parameters on nanoparticles loaded with gatifloxacin for ocular drug delivery. Int J Acad Sci Res. 2014;3:1-2.

- Jünemann D, Dressman J. Analytical methods for dissolution testing of nanosized drugs. J Pharm Pharmaco. 2012;64:931-43.

- Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. Int J Pharm. 2015; 478:540-52.

- Junyaprasert VB, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. A J Pharm Sci. 2015; 10:13-23.

- Fu X, Kong W, Zhang Y, Jiang L, Wang J, Lei J. Novel solid-solid phase change materials with biodegradable trihydroxy surfactants for thermal energy storage. RSC Advances. 2015;5:68881-9.

- Mishra B, Sahoo J, Dixit PK. Fabrication of cinnarizine nanosuspensions by ultrasonication technique: a systematic study of formulation parameters on particle size and in-vitro dissolution. Biopharm J. 2017;1:12-21.

- Vora C,Patadia R, Mittal K, MashruR. Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. Pharm Dev Tech. 2016;21:847-55.




Fatal error: Call to a member function getGalleyLabel() on null in /home/innowar1/public_html/journals/cache/t_compile/%%38^38D^38D7420B%%article.tpl.php on line 189